"10.1371_journal.pone.0058890","plos one","2013-03-14T00:00:00Z","Jonas Tind Hansen; Christina Lyngs√∏; Tobias Speerschneider; Pernille B L Hansen; C√©line Gal√©s; David M Weiner; S√∏ren P Sheikh; Ethan S Burstein; Jakob Lerche Hansen","Laboratory for Molecular Cardiology, Department of Biomedical Sciences and The Danish National Research Foundation Centre for Cardiac Arrhythmia, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark; Department of Clinical Biochemistry, Glostrup Hospital, Glostrup, Denmark; Cardiovascular and Renal Research, University of Southern Denmark, Odense C, Denmark; Institut des Maladies M√©taboliques et Cardiovasculaires (I2MC), Institut National de la Sant√© et de la Recherche M√©dicale, Universit√© Toulouse III Paul Sabatier, Toulouse, France; Proteostasis Therapeutics, Inc., Cambridge, Massachusetts, United States of America; Department of Clinical Biochemistry and Pharmacology, Laboratory for Molecular and Cellular Cardiology, Odense University Hospital, Odense, Denmark; ACADIA Pharmaceuticals, Inc., San Diego, California, United States of America; Diabetes NBEs and Obesity biology, Novo Nordisk, M√•l√∏v, Denmark","Conceived and designed the experiments: JTH CL PBLH CG DMW SPS ESB JLH. Performed the experiments: JTH TS PBLH JLH. Analyzed the data: JTH CL TS PBLH ESB JLH. Contributed reagents/materials/analysis tools: CG DMW SPS ESB. Wrote the paper: JTH CL ESB JLH.","The authors have read the journal‚Äôs policy and have the following conflicts. JLH is an employee of Novo Nordisk and owns stock in Novo Nordisk. ESB is an employee of ACADIA Pharmaceuticals Inc. and owns stock in ACADIA. RSAT‚¢ is a patented functional screening technology owned by ACADIA. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","03","Jonas Tind Hansen","JTH",9,TRUE,8,4,6,4,TRUE,TRUE,FALSE,0,NA,FALSE
